Page last updated: 2024-11-03

risperidone and Muscular Weakness

risperidone has been researched along with Muscular Weakness in 2 studies

Risperidone: A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA.
risperidone : A member of the class of pyridopyrimidines that is 2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one carrying an additional 2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl group at position 2.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Vale, TC1
Freitas, Dda S1
Maciel, RO1
Miranda, EC1
Cardoso, F1
Kiliçaslan, F1
Bayazit, H1
Kandemir, H1
Çalik, M1
Kandemir, SB1
Guler, K1

Other Studies

2 other studies available for risperidone and Muscular Weakness

ArticleYear
Teaching Video NeuroImages: hemichorea-hemiballismus secondary to nonketotic hyperglycemia.
    Neurology, 2013, Apr-16, Volume: 80, Issue:16

    Topics: Antipsychotic Agents; Brain; Chorea; Diabetes Mellitus, Type 2; Dyskinesias; Female; Humans; Hypergl

2013
Motor Weakness Related to Risperidone.
    Journal of child and adolescent psychopharmacology, 2015, Volume: 25, Issue:6

    Topics: Antipsychotic Agents; Child Behavior Disorders; Child, Preschool; Humans; Intellectual Disability; M

2015